Bortolasci and colleagues [59] conducted two studies: the first to examine PON1 status (PON1 activity and functional PONQ192R polymorphism based on a 2-substrate assay) in patients with major depression and bipolar disorder with nicotine dependence. Here, PON1 is linked to major depressive disorder.